Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855

Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities

Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174

Gene ontology analysis for RNA-seq: accounting for selection bias

Young, M. D., Wakefield, M. J., Smyth, G. K., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-2-r14 · Cited by 7,107

The PRIDE database and related tools and resources in 2019: improving support for quantification data

Pérez-Riverol, Y., Csordas, A., Bai, J.-W., Bernal-Llinares, M., Hewapathirana, S., Kundu, D. J., Inuganti, A., Griss, J., Mayer, G., Eisenacher, M., et al. (2018) · Nucleic Acids Res. · doi:10.1093/nar/gky1106 · Cited by 6,216

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430

Molecular mechanisms in MASLD/MASH-related HCC

Wang, X., Zhang, L., & Dong, B. (2024) · Hepatology · doi:10.1097/hep.0000000000000786 · Cited by 193

Epithelial–mesenchymal transition in tissue repair and degeneration

Youssef, K. K., & Nieto, M. A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00733-z · Cited by 165

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158

Loss of liver function in chronic liver disease: An identity crisis

Berasain, C., Arechederra, M., Argemí, J., Fernández-Barrena, M. G., & Avila, M. A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.001 · Cited by 99

A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis

Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems

Liu, J., Liu, J., Mu, W., Ma, Q., Zhai, X., Jin, B., Liu, Y., & Zhang, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c02380 · Cited by 74

Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis

Xiao, Y., Batmanov, K., Hu, W., Zhu, K., Tom, A. Y., Guan, D., Jiang, C., Cheng, L., McCright, S. J., Yang, E. C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9653 · Cited by 69

Liver regeneration: Cellular origin and molecular mechanisms

Huang, R. C. C., Zhang, X., Gracia‐Sancho, J., & Xie, W. (2022) · Liver International · doi:10.1111/liv.15174 · Cited by 69

Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma

Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C. J., Ramos‐Molina, B., & Gurzov, E. N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100811 · Cited by 62

Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity

Greatorex, S., Kaur, S., Xirouchaki, C. E., Goh, P. K., Wiede, F., Genders, A. J., Tran, M., Jia, Y., Raajendiran, A., Brown, W. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162533 · Cited by 61

Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines

Gong, L., Wei, F., Gonzalez, F. J., & Li, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000182 · Cited by 61

Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periostin

Xie, W., Gan, J., Zhou, X., Tian, H., Pan, X., Liu, W., Li, X., Du, J., Xu, A., Zheng, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.020 · Cited by 55

GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases

Li, Z., Zhang, H., Li, Q., Feng, W., Jia, X., Zhou, R., Huang, Y., Li, Y., Hu, Z., Hu, X., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02257-1 · Cited by 55

The role of N-glycosylation modification in the pathogenesis of liver cancer

Hu, M., Zhang, R., Yang, J., Zhao, C., Liu, W., Huang, Y., Lyu, H., Xiao, S., Guo, D. S., Zhou, C., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05733-z · Cited by 53

Spatial genomics: mapping human steatotic liver disease

Matchett, K. P., Paris, J., Teichmann, S. A., & Henderson, N. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00915-2 · Cited by 53

HNF4A modulates glucocorticoid action in the liver

Hunter, A. L., Poolman, T. M., Kim, D., Gonzalez, F. J., Bechtold, D. A., Loudon, A. S. I., Iqbal, M., & Ray, D. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110697 · Cited by 49

Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis

Zhang, L., Deng, W., Huang, Q., Zhang, J., Wang, Y., Zhou, T., Xing, L., & Jiang, H. (2024) · Advanced Materials · doi:10.1002/adma.202311474 · Cited by 48

Liver-specific actions of GH and IGF1 that protect against MASLD

Kineman, R. D., del Río-Moreno, M., & Waxman, D. J. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01037-0 · Cited by 44

IL6 supports long-term expansion of hepatocytes in vitro

Guo, R., Jiang, M., Wang, G., Li, B., Jia, X., Ai, Y., Chen, S., Tang, P., Liu, A., Yuan, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35167-8 · Cited by 36

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases

Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33

The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression

Wang, G., Duan, J., Pu, G., Ye, C., Li, Y., Xiu, W., Xu, J., Liu, B., Zhu, Y., & Wang, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166413 · Cited by 33

Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming

Aguilar‐Bravo, B., Ariño, S., Blaya, D., Pose, E., de la Torre, R. A. M. G., Latasa, M. U., Martínez–Sánchez, C., Zanatto, L., Sererols-Viñas, L., Vilà, P. C., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.013 · Cited by 33

Regulation of systemic metabolism by tissue-resident immune cell circuits

Li, J. H., Hepworth, M. R., & O’Sullivan, T. E. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.001 · Cited by 36

Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease

Pedersen, F. B., Akimov, V., Teuchler, M., Terkelsen, M. K., Wernberg, C. W., Larsen, F. T., Hallenborg, P., Lauridsen, M. M., Krag, A. A., Mandrup, S., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00780-3 · Cited by 32

Distinct hepatocyte identities in liver homeostasis and regeneration

Chen, F., Schönberger, K., & Tchorz, J. S. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100779 · Cited by 30

Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease

Zhang, C., Rehman, M., Tian, X., Pei, S. L. C., Gu, J., Bell, T. A., Dong, K., Tham, M. S., Cai, Y., Wei, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48025-6 · Cited by 30

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis

Zhang, J., Shen, Y., Chen, X.-Y., Jiang, M.-L., Yuan, F.-H., Xie, S.-L., Zhang, J., & Xu, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1115890 · Cited by 31

EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis

Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29

Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans

Pan, C., Liu, J., Gao, Y., Yang, M., Hu, H., Liu, C., Qian, M., Yuan, H.-Y., Yang, S., Zheng, M.-H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.018 · Cited by 27

Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging

Occean, J. R., Yang, N., Sun, Y., Dawkins, M. S., Munk, R. B., Belair, C., Dar, S. A., Anerillas, C., Wang, L., Shi, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50725-y · Cited by 30

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Das, S. R., Finney, A. C., Anand, S. K., Rohilla, S., Liu, Y., Pandey, N. O., Ghrayeb, A., Kumar, D., Núñez, K., Liu, Z., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01134-4 · Cited by 28

Hepatocyte survival and proliferation by fibroblast growth factor 7 attenuates liver inflammation, and fibrogenesis during acute liver injury via paracrine mechanisms

Geervliet, E., Terstappen, L. W. M. M., & Bansal, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115612 · Cited by 26

Lactate and lactylation: novel perspectives on fibrosis pathogenesis and therapeutic directions

Liang, H., Xu, L., & Yang, Y. A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06748-0 · Cited by 29

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression

Banerjee, A., & Farci, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168641 · Cited by 25

Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling

Li, Y., Xiu, W., Xu, J., Chen, X., Wang, G., Duan, J., Sun, L., Liu, B., Xie, W., Pu, G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.162402 · Cited by 23

Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia

Kaltenecker, D., Schmidt, S. F., Weber, P., Loft, A., Morigny, P., Machado, J., Geppert, J., Saul, K. B., Benedikt, P., Molocea, C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.039 · Cited by 28

ChemPert: mapping between chemical perturbation and transcriptional response for non-cancer cells

Zheng, M., Okawa, S., Bravo, M., Chen, F., Martínez‐Chantar, M. L., & del Sol, A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac862 · Cited by 21

Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death

Lambrecht, R., Delgado, M. E., Gloe, V., Schuetz, K., Plazzo, A. P., Franke, B., Phan, T. S., Fleming, J. R., Mayans, O. M., & Brunner, T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113513 · Cited by 23

The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models

Aki, D., Hayakawa, T., Srirat, T., Shichino, S., Ito, M., Saitoh, S.-I., Mise-Omata, S., & Yoshimura, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175305 · Cited by 22

GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation

Rizza, S., Leo, L. D., Pecorari, C., Giglio, P., Faienza, F., Montagna, C., Maiani, E., Puglia, M., Bosisio, F. M., Petersen, T. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.111997 · Cited by 20

Interrogating mechanisms of liver fibrosis with omics

Oakley, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00567-6 · Cited by 19

Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?

Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19

FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis

Wen, Y., Zou, Z.-Y., Zhao, G., Zhang, M., Zhang, Y., Wang, G., Shi, J., Wang, Y.-Y., Song, Y.-Y., Wang, H., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01329-1 · Cited by 19

Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk

Martins, M. C., Dixon, E. D., Lupo, G., Claudel, T., Trauner, M., & Rombouts, K. (2024) · Liver International · doi:10.1111/liv.16117 · Cited by 22

Cell competition in primary and metastatic colorectal cancer

van Luyk, M. E., García, A. K., Λάμπρου, Μ., & Suijkerbuijk, S. J. E. (2024) · Oncogenesis · doi:10.1038/s41389-024-00530-5 · Cited by 20

GLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease

Jetten, A. M., Scoville, D. W., & Kang, H. S. (2022) · Cells · doi:10.3390/cells11111833 · Cited by 17

Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease

Dubois, V., Lefèbvre, P., Staels, B., & Eeckhoute, J. (2024) · Gut · doi:10.1136/gutjnl-2023-331741 · Cited by 17

Unraveling DINCH – Induced hepatotoxicity mechanisms via network toxicology and molecular docking with experimental validation

Xin, J., Zhou, C., Wang, Y., Chen, H., Yin, K., Gao, L., & Shao, S. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118305 · Cited by 16

Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease

Ariño, S., Ferrer‐Lorente, R., Serrano, G., Zanatto, L., de la Torre, R. A. M. G., Gratacós‐Ginès, J., Rubio, A. B., Pérez-Guasch, M., Mateos-Sánchez, C., Aguilar‐Bravo, B., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.07.014 · Cited by 19

GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation

Zhang, H., Zhou, P., Xing, W., Chen, L., Zhou, Y., Yang, H., Fu, K., & Liu, Z. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.015 · Cited by 15

Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective

Fu, Y., Wang, Z., & Qin, H. (2024) · Metabolites · doi:10.3390/metabo14040218 · Cited by 15

CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion

Rho, H. K., Kim, S., Kim, S. U., Kim, J. W., Lee, S. H., Park, S., Escorcia, F. E., Chung, J., & Song, J. (2024) · Nature Communications · doi:10.1038/s41467-024-53002-0 · Cited by 18

Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression

Huerta, M., Franco-Serrano, L., Amela, I., Perez-Pons, J. A., Piñol, J., Mozo-Villarias, Á., Querol, E., & Cedano, J. A. (2023) · Cells · doi:10.3390/cells12020235 · Cited by 14

Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis

Karri, K., & Waxman, D. J. (2023) · RNA · doi:10.1261/rna.079580.123 · Cited by 15

Lack of thyroid hormone receptor beta is not detrimental for non-alcoholic steatohepatitis progression

López‐Alcántara, N., Oelkrug, R., Sentis, S. C., Kirchner, H., & Mittag, J. (2023) · iScience · doi:10.1016/j.isci.2023.108064 · Cited by 14

HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis

Yang, Y., Liu, X., Chen, H., Wang, P., Yao, S., Zhou, B., Yin, R., Li, C., Wu, C., Yang, X., et al. (2022) · FEBS Journal · doi:10.1111/febs.16430 · Cited by 14

Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma

Sun, Y.-D., Zhang, H., Li, Y., & Han, J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189086 · Cited by 13

Hydroxysteroid 17β‐dehydrogenase 13 ( Hsd17b13 ) knockdown attenuates liver steatosis in high‐fat diet obese mice

Mahmood, S., Morrice, N., Thompson, D., Milanizadeh, S., Wilson, S., Whitfield, P. D., Mcilroy, G. D., Rochford, J. J., & Mody, N. (2025) · Experimental Physiology · doi:10.1113/ep092535 · Cited by 13

Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice

Liu, T., Wang, Q., Zhou, L., Zhang, P., Mi, L., Qiu, X., Chen, Z., Kuang, H., Li, S., & Lin, J. D. (2022) · Hepatology · doi:10.1002/hep.32719 · Cited by 14

Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis

Beyoğlu, D., Huang, P., Skelton-Badlani, D., Zong, C., Popov, Y. V., & Idle, J. R. (2023) · Cells · doi:10.3390/cells12030485 · Cited by 12

Metabolism and bioenergetics in the pathophysiology of organ fibrosis

Miguel, V., Alcalde‐Estévez, E., Sirera, B., Rodríguez‐Pascual, F., & Lamas, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.001 · Cited by 13

The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche

Gonzalez‐Sanchez, E., Vaquero, J., Caballero‐Díaz, D., Grzelak, J., Fusté, N. P., Bertrán, E., Amengual, J., García‐Sáez, J., Martín‐Mur, B., Gut, M. O., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6299 · Cited by 12

Chemically induced revitalization of damaged hepatocytes for regenerative liver repair

Lin, P., Bai, Y., Nian, X.-X., Chi, J., Chen, T., Zhang, J., Zhang, W., Zhou, B., Liu, Y., & Zhao, Y. (2023) · iScience · doi:10.1016/j.isci.2023.108532 · Cited by 11

Purification of GFP-tagged nuclei from frozen livers of INTACT mice for RNA- and ATAC-sequencing

Loft, A., Herzig, S., & Schmidt, S. F. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100805 · Cited by 11

Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function

Wolff, G., Sakurai, M., Mhamane, A., Troullinaki, M., Maida, A., Deligiannis, I. K., Yin, K., Weber, P., Morgenstern, J., Wieder, A., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101487 · Cited by 12

Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice

Quitete, F. T., Teixeira, A. V. S., Peixoto, T. C., Martins, B. C., Atella, G. C., Resende, Â. C., Mucci, D. D. B., Martins, F. F., & Daleprane, J. B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308334 · Cited by 10

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163

Skytthe, M. K., Pedersen, F. B., Wernberg, C. W., Chandran, V. I., Krag, A. A., Caterino, T. D., Mandacaru, S. C., Blagoev, B., Lauridsen, M. M., Detlefsen, S., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.03.006 · Cited by 9

Emerging roles of RNA‐binding proteins in fatty liver disease

Adesanya, O. A., Das, D., & Kalsotra, A. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1840 · Cited by 9

TSC22D4 promotes TGFβ1-induced activation of hepatic stellate cells

Sakurai, M., Weber, P., Wolff, G., Wieder, A., Szendroedi, J., Herzig, S., & Üstünel, B. E. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.05.100 · Cited by 9

CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells

Calixto-Tlacomulco, S., Luna-Reyes, I., Delgado‐Coello, B., Gutiérrez‐Vidal, R., Reyes‐Grajeda, J. P., & Mas‐Oliva, J. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102937 · Cited by 9

Thwarting Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) with Common Bean: Dose- and Sex-Dependent Protection against Hepatic Steatosis

Lutsiv, T., McGinley, J. N., Neil, E. S., Foster, M. T., & Thompson, H. J. (2023) · Nutrients · doi:10.3390/nu15030526 · Cited by 10

Interdisciplinary advances reshape the delivery tools for effective NASH treatment

Chen, L., & Wang, Y. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101730 · Cited by 9

Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression

Sonkar, R., Ma, H., & Waxman, D. J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae057 · Cited by 7

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition

Shen, T. K., Vignane, T., Gilglioni, E. H., Traini, L., Kalaitsidou, E., Conan, P., Li, A., St‐Pierre‐Wijckmans, W., Herranz, J. M., Elvira, B., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103809 · Cited by 8

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Ye, B., Yu, M., Yue, M., Yin, M., Zhang, C., Wang, Q., Ding, X., Shen, W., & Zhao, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-38144-3 · Cited by 8

The chromatin remodeling protein BRG1 mediates Ang II induced pro-fibrogenic response in renal fibroblasts

Hong, W., Zhu, Y., Lin, Y., Tang, S., Chen, J., Xu, L., Jiang, J., Zong, Y., Zhang, Y., Sun, A., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122320 · Cited by 9

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Ntambi, J.-N., Kalyesubula, M., Cootway, D., Lewis, S. A., Phang, Y. X., Liu, Z., O’Neill, L. M., Lefers, L., Huff, H., Miller, J. R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159538 · Cited by 9

Dynamic enhancer interactome promotes senescence and agingPreprint

Wang, L., Donahue, G., Zhang, C., Havas, A. P., Lei, X., Xu, C., Wang, W., Vahedi, G., Adams, P. D., & Berger, S. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.22.541769 · Cited by 8

Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity

Pérez‐Schindler, J., Vargas‐Fernández, E., Karrer‐Cardel, B., Ritz, D., Schmidt, A., & Handschin, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-15731-4 · Cited by 7

An extended transcription factor regulatory network controls hepatocyte identity

Dubois‐Chevalier, J., Gheeraert, C., Berthier, A., Boulet, C., Dubois, V., Guille, L., Fourcot, M., Marot, G., Gauthier, K., Dubuquoy, L., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357020 · Cited by 6

Mesenchymal drift: A convergent framework for the hallmarks of aging

Lu, J. Y., Tu, W. B., Ma, S., Ma, Z., Imaz-Rosshandler, I., Weng, M., Qu, J., Esteban, C. R., Reddy, P., Liu, G.-H., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.020 · Cited by 10

Alterations in the hepatocyte epigenetic landscape in steatosis

Maji, R. K., Czepukojc, B., Scherer, M., Tierling, S., Cadenas, C., Gianmoena, K., Gasparoni, N., Nordström, K. J. V., Gasparoni, G., Laggai, S., et al. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00504-8 · Cited by 7

NHE1 regulation in NAFLD in vitro contributes to hepatocyte injury and HSC crosstalk

Sjøgaard-Frich, L. M., Henriksen, M. S., Lam, S., Birkbak, F. J., Czaplińska, D., Flinck, M., & Pedersen, S. F. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0099 · Cited by 6

Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis

Das, M., Savidge, B. O., Pearl, J. E., Yates, T. E., Miles, G. J., Pareek, M., Haldar, P., & Cooper, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012565 · Cited by 6

Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD

Dam, T. V., Toft, N. I., & Grøntved, L. (2022) · Cells · doi:10.3390/cells11050870 · Cited by 6

Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids

Sarıyar, E., & Karagonlar, Z. F. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231193421 · Cited by 6

High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model

Taguchi, D., Shirakami, Y., Sakai, H., Maeda, T., Miwa, T., Kubota, M., Imai, K., Ibuka, T., & Shimizu, M. (2024) · Nutrients · doi:10.3390/nu16152506 · Cited by 5

Nrf2 deficiency causes hepatocyte dedifferentiation and reduced albumin production in an experimental extrahepatic cholestasis model

Wang, G., Garcia, V., Lee, J., Yanum, J. A., Lin, J., Jiang, H., & Dai, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269383 · Cited by 5

Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy

Ma, M., Wang, X., Liu, X., Han, Y., Chu, Y., Guan, Y., & Liu, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01435-4 · Cited by 5

Targeted blockade of extracellular vesicles-mediated profibrotic vicious circle using EVs-based dual-drug delivery system to prevent liver fibrosis

Sun, J., Shen, Y., Wang, X., Men, R., Xing, X., Lv, L., Yang, F., Shen, M., Zheng, Y., Fan, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03940-8 · Cited by 4

Lipid-induced granules in hepatocytes alleviate liver fibrosis

Li, Y., Lei, T., Nie, W., Ma, M., Zhao, W., Zhou, Y., Liu, Y., Wang, M., Jia, K., Liu, S., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2025.12.015 · Cited by 7

Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesityPreprint

Hung, Y.-H., Sritharan, R., Vohl, M., Ilkayeva, O., Biertho, L. D., Tchernof, A., White, P. J., & Sethupathy, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.20.457162 · Cited by 4

Indirubin alleviates CCl4-induced liver fibrosis by regulation of TGF-β-mediated signaling pathways.

Li, X., Yao, Y., & Lin, W. (2023) · PubMed Central · doi:10.22038/ijbms.2023.70476.15319 · Cited by 3

Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes

Wada, T., Takeda, Y., Okekawa, A., Komatsu, G., Iwasa, Y., Onogi, Y., Takasaki, I., Hamashima, T., Sasahara, M., Tsuneki, H., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75713-6 · Cited by 6

The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease

Grandt, J., Johansen, C. D., Jensen, A. H., Werge, M. P., Rashu, E. B., Møller, A., Junker, A. E., Hobolth, L., Mortensen, C., Vyberg, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0307345 · Cited by 3

Dietary olive oil intake induces female-specific hepatic lipid accumulation without metabolic impairment in mice

Komiya, Y., Sugiyama, M., Koyama, C., Kameshima, S., Ochiai, M., Adachi, Y., Yokoyama, I., Fukasawa, H., Yoshioka, K., & Arihara, K. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.02.001 · Cited by 3

Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis

Wang, Y., Yu, H., Cen, Z., Zhu, Y., & Wu, W. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100267 · Cited by 3

In Silico Treatment: a computational framework for animal model selection and drug assessmentPreprint

Picart‐Armada, S., Becker, K., Kästle, M., Krenkel, O., Simon, E. S., Tenbaum, S. P., Strobel, B., Geillinger‐Kästle, K. E., Fundel‐Clemens, K., Matera, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.17.599264 · Cited by 3

Transcriptional factor RUNX1: A potential therapeutic target for fibrotic pulmonary disease

LIU, J., WANG, F., YUAN, B., & Luo, F. (2023) · Biocell · doi:10.32604/biocell.2023.026148 · Cited by 3

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis

Wang, Z.-Y., Keogh, A., Waldt, A., Cuttat, R., Neri, M., Zhu, S., Schuierer, S., Ruchti, A., Crochemore, C., Knehr, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98806-y · Cited by 103

Identification of NASH-associated signaling networks in murine hepatic stellate cells

Ravnskjær, K. (2017) · University of Southern Denmark Research Portal (University of Southern Denmark)

Understanding the cellular interactome of non-alcoholic fatty liver disease

Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116

Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review)

Zhou, X., Yang, C., Weng, Z., & 李立华 (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.6020

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95